North America Topical Scar Treatment Market

North America Topical Scar Treatment Market Size, Share & Trends Analysis Report By End-use, By Scar Type (Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks), By Product, By Country and Growth Forecast, 2023 - 2030

Report Id: KBV-21302 Publication Date: March-2024 Number of Pages: 108
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Topical Scar Treatment Market, by End-use
1.4.2 North America Topical Scar Treatment Market, by Scar Type
1.4.3 North America Topical Scar Treatment Market, by Product
1.4.4 North America Topical Scar Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. North America Topical Scar Treatment Market by End-use
4.1 North America Hospitals Market by Country
4.2 North America Clinics Market by Country
4.3 North America Homecare Market by Country

Chapter 5. North America Topical Scar Treatment Market by Scar Type
5.1 North America Atrophic Scars Market by Country
5.2 North America Hypertrophic & Keloid Scars Market by Country
5.3 North America Contracture Scars Market by Country
5.4 North America Stretch Marks Market by Country

Chapter 6. North America Topical Scar Treatment Market by Product
6.1 North America Creams Market by Country
6.2 North America Gels Market by Country
6.3 North America Silicon Sheets Market by Country
6.4 North America Others Market by Country

Chapter 7. North America Topical Scar Treatment Market by Country
7.1 US Topical Scar Treatment Market
7.1.1 US Topical Scar Treatment Market by End-use
7.1.2 US Topical Scar Treatment Market by Scar Type
7.1.3 US Topical Scar Treatment Market by Product
7.2 Canada Topical Scar Treatment Market
7.2.1 Canada Topical Scar Treatment Market by End-use
7.2.2 Canada Topical Scar Treatment Market by Scar Type
7.2.3 Canada Topical Scar Treatment Market by Product
7.3 Mexico Topical Scar Treatment Market
7.3.1 Mexico Topical Scar Treatment Market by End-use
7.3.2 Mexico Topical Scar Treatment Market by Scar Type
7.3.3 Mexico Topical Scar Treatment Market by Product
7.4 Rest of North America Topical Scar Treatment Market
7.4.1 Rest of North America Topical Scar Treatment Market by End-use
7.4.2 Rest of North America Topical Scar Treatment Market by Scar Type
7.4.3 Rest of North America Topical Scar Treatment Market by Product

Chapter 8. Company Profiles
8.1 Smith & Nephew PLC
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional and Segmental Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Lumenis Be Ltd.
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.2.2.2 Product Launches and Product Expansions:
8.2.3 SWOT Analysis
8.3 Merz Pharma GmbH & Co. KGaA
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.3 SWOT Analysis
8.4 Sonoma Pharmaceuticals, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.6 SWOT Analysis
8.5 Molnlycke Health Care AB
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 Suneva Medical, Inc.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Product Launches and Product Expansions:
8.6.3 SWOT Analysis
8.7 Perrigo Company PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.8.3 SWOT Analysis
8.9 Newmedical Technology Inc.
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Integra LifeSciences Holdings Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo